Cargando…

Probe-Based Confocal Laser Endomicroscopy versus White-Light Endoscopy with Narrow-Band Imaging for Predicting and Collecting Residual Cancer Tissue in Patients with Gastric Cancer Receiving Chemotherapy

SIMPLE SUMMARY: Collecting appropriate gastric cancer (GC) tissues is critical for molecular biology research or the development of new target drugs for cases resistant to chemotherapy. Chemotherapy may reduce or alter the distribution of GC tissue on the surface, making the detection of GC tissue d...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Yuna, Kim, Hyunki, Jung, Minkyu, Rha, Sun Young, Chung, Hyun Cheol, Lee, Sang Kil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454914/
https://www.ncbi.nlm.nih.gov/pubmed/36077854
http://dx.doi.org/10.3390/cancers14174319
_version_ 1784785464429903872
author Kim, Yuna
Kim, Hyunki
Jung, Minkyu
Rha, Sun Young
Chung, Hyun Cheol
Lee, Sang Kil
author_facet Kim, Yuna
Kim, Hyunki
Jung, Minkyu
Rha, Sun Young
Chung, Hyun Cheol
Lee, Sang Kil
author_sort Kim, Yuna
collection PubMed
description SIMPLE SUMMARY: Collecting appropriate gastric cancer (GC) tissues is critical for molecular biology research or the development of new target drugs for cases resistant to chemotherapy. Chemotherapy may reduce or alter the distribution of GC tissue on the surface, making the detection of GC tissue during upper endoscopy challenging. Our study showed that probe-based confocal laser endomicroscopy (pCLE) is superior to white-light endoscopy (WLE) with magnifying narrow-band imaging (M-NBI) in terms of accuracy for diagnosing residual cancer in GC patients receiving chemotherapy. pCLE might be considered when it is necessary to confirm the presence of residual cancer and get tissue samples from GC patients receiving chemotherapy. ABSTRACT: In cases of progression despite chemotherapy, collecting gastric cancer (GC) tissues might be helpful for molecular biology research or the development of new target drugs for treating cases that are refractory to chemotherapy. Chemotherapy, however, may reduce or alter the distribution of GC tissue on the surface, making the detection of GC tissue during upper endoscopy challenging. Probe-based confocal laser endomicroscopy (pCLE) is a new technology that enables histological diagnosis by magnifying the mucous membrane to a microscopic level. Here, we evaluated whether pCLE could increase the yield of endoscopic biopsy for GC compared to white-light endoscopy (WLE) with magnifying narrow-band imaging (M-NBI) in GC patients receiving chemotherapy with its powerful imaging technique. Patients underwent WLE/M-NBI and pCLE for the detection of residual GC for the purpose of response evaluation or clinical trial registration. After WLE/M-NBI and pCLE, each residual GC lesion was biopsied for histological analysis. A total of 23 patients were enrolled between January 2018 and June 2020. Overall, pCLE showed significantly higher sensitivity and negative predictive value than WLE/M-NBI. The accuracy of pCLE was superior to that of WLE/M-NBI. Moreover, pCLE showed better predictive ability for residual GC than WLE/M-NBI, while WLE/M-NBI and pCLE showed inconsistent results. pCLE diagnosed residual GC more accurately than WLE/M-NBI, which resulted in an increased number of GC tissues collected during the endoscopic biopsy.
format Online
Article
Text
id pubmed-9454914
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-94549142022-09-09 Probe-Based Confocal Laser Endomicroscopy versus White-Light Endoscopy with Narrow-Band Imaging for Predicting and Collecting Residual Cancer Tissue in Patients with Gastric Cancer Receiving Chemotherapy Kim, Yuna Kim, Hyunki Jung, Minkyu Rha, Sun Young Chung, Hyun Cheol Lee, Sang Kil Cancers (Basel) Article SIMPLE SUMMARY: Collecting appropriate gastric cancer (GC) tissues is critical for molecular biology research or the development of new target drugs for cases resistant to chemotherapy. Chemotherapy may reduce or alter the distribution of GC tissue on the surface, making the detection of GC tissue during upper endoscopy challenging. Our study showed that probe-based confocal laser endomicroscopy (pCLE) is superior to white-light endoscopy (WLE) with magnifying narrow-band imaging (M-NBI) in terms of accuracy for diagnosing residual cancer in GC patients receiving chemotherapy. pCLE might be considered when it is necessary to confirm the presence of residual cancer and get tissue samples from GC patients receiving chemotherapy. ABSTRACT: In cases of progression despite chemotherapy, collecting gastric cancer (GC) tissues might be helpful for molecular biology research or the development of new target drugs for treating cases that are refractory to chemotherapy. Chemotherapy, however, may reduce or alter the distribution of GC tissue on the surface, making the detection of GC tissue during upper endoscopy challenging. Probe-based confocal laser endomicroscopy (pCLE) is a new technology that enables histological diagnosis by magnifying the mucous membrane to a microscopic level. Here, we evaluated whether pCLE could increase the yield of endoscopic biopsy for GC compared to white-light endoscopy (WLE) with magnifying narrow-band imaging (M-NBI) in GC patients receiving chemotherapy with its powerful imaging technique. Patients underwent WLE/M-NBI and pCLE for the detection of residual GC for the purpose of response evaluation or clinical trial registration. After WLE/M-NBI and pCLE, each residual GC lesion was biopsied for histological analysis. A total of 23 patients were enrolled between January 2018 and June 2020. Overall, pCLE showed significantly higher sensitivity and negative predictive value than WLE/M-NBI. The accuracy of pCLE was superior to that of WLE/M-NBI. Moreover, pCLE showed better predictive ability for residual GC than WLE/M-NBI, while WLE/M-NBI and pCLE showed inconsistent results. pCLE diagnosed residual GC more accurately than WLE/M-NBI, which resulted in an increased number of GC tissues collected during the endoscopic biopsy. MDPI 2022-09-03 /pmc/articles/PMC9454914/ /pubmed/36077854 http://dx.doi.org/10.3390/cancers14174319 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kim, Yuna
Kim, Hyunki
Jung, Minkyu
Rha, Sun Young
Chung, Hyun Cheol
Lee, Sang Kil
Probe-Based Confocal Laser Endomicroscopy versus White-Light Endoscopy with Narrow-Band Imaging for Predicting and Collecting Residual Cancer Tissue in Patients with Gastric Cancer Receiving Chemotherapy
title Probe-Based Confocal Laser Endomicroscopy versus White-Light Endoscopy with Narrow-Band Imaging for Predicting and Collecting Residual Cancer Tissue in Patients with Gastric Cancer Receiving Chemotherapy
title_full Probe-Based Confocal Laser Endomicroscopy versus White-Light Endoscopy with Narrow-Band Imaging for Predicting and Collecting Residual Cancer Tissue in Patients with Gastric Cancer Receiving Chemotherapy
title_fullStr Probe-Based Confocal Laser Endomicroscopy versus White-Light Endoscopy with Narrow-Band Imaging for Predicting and Collecting Residual Cancer Tissue in Patients with Gastric Cancer Receiving Chemotherapy
title_full_unstemmed Probe-Based Confocal Laser Endomicroscopy versus White-Light Endoscopy with Narrow-Band Imaging for Predicting and Collecting Residual Cancer Tissue in Patients with Gastric Cancer Receiving Chemotherapy
title_short Probe-Based Confocal Laser Endomicroscopy versus White-Light Endoscopy with Narrow-Band Imaging for Predicting and Collecting Residual Cancer Tissue in Patients with Gastric Cancer Receiving Chemotherapy
title_sort probe-based confocal laser endomicroscopy versus white-light endoscopy with narrow-band imaging for predicting and collecting residual cancer tissue in patients with gastric cancer receiving chemotherapy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454914/
https://www.ncbi.nlm.nih.gov/pubmed/36077854
http://dx.doi.org/10.3390/cancers14174319
work_keys_str_mv AT kimyuna probebasedconfocallaserendomicroscopyversuswhitelightendoscopywithnarrowbandimagingforpredictingandcollectingresidualcancertissueinpatientswithgastriccancerreceivingchemotherapy
AT kimhyunki probebasedconfocallaserendomicroscopyversuswhitelightendoscopywithnarrowbandimagingforpredictingandcollectingresidualcancertissueinpatientswithgastriccancerreceivingchemotherapy
AT jungminkyu probebasedconfocallaserendomicroscopyversuswhitelightendoscopywithnarrowbandimagingforpredictingandcollectingresidualcancertissueinpatientswithgastriccancerreceivingchemotherapy
AT rhasunyoung probebasedconfocallaserendomicroscopyversuswhitelightendoscopywithnarrowbandimagingforpredictingandcollectingresidualcancertissueinpatientswithgastriccancerreceivingchemotherapy
AT chunghyuncheol probebasedconfocallaserendomicroscopyversuswhitelightendoscopywithnarrowbandimagingforpredictingandcollectingresidualcancertissueinpatientswithgastriccancerreceivingchemotherapy
AT leesangkil probebasedconfocallaserendomicroscopyversuswhitelightendoscopywithnarrowbandimagingforpredictingandcollectingresidualcancertissueinpatientswithgastriccancerreceivingchemotherapy